DGX
Quest Diagnostics Incorporated
233.30$
+1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.0% | 23.0% | 6.5% | 15.0% | 14.3% | 17.7% | 11.8% | 19.7% | 20.0% | 16.6% | 9.6% | 15.4% | 15.3% | |
| 4.8% | 4.8% | 4.9% | 4.9% | 5.0% | 5.2% | 5.3% | 5.2% | 5.0% | 5.2% | 5.1% | 4.8% | 5.0% | |
| 0.8% | 0.8% | 0.9% | 0.8% | 0.8% | 1.0% | 0.8% | 0.8% | 0.7% | 0.9% | 0.7% | 0.8% | 0.8% | |
| 0.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.4% | 7.6% | -7.9% | -0.3% | -1.7% | 0.5% | -3.4% | 2.0% | 1.2% | 2.3% | -7.3% | 2.7% | -0.3% | |
| 4.6% | 3.1% | 4.4% | 3.8% | 4.3% | 4.7% | 4.4% | 3.9% | 5.1% | 5.6% | 3.9% | 4.5% | 4.8% | |
| -41.3% | -5.0% | -9.0% | -8.3% | -65.6% | -19.2% | -4.3% | -4.5% | -7.1% | -6.8% | -5.3% | -4.4% | -5.9% | |
| 3.5% | 3.5% | 3.3% | 3.5% | 3.4% | 3.2% | 3.2% | 3.3% | 3.2% | 3.2% | 3.0% | 3.2% | 3.1% | |
| 2.6% | -12.0% | -1.0% | – | 0.0% | -5.8% | 1.1% | 1.5% | -5.3% | -10.7% | – | -3.4% | – | |
| -1.8% | – | – | – | 74.2% | 0.0% | -14.5% | -7.8% | 0.0% | 0.0% | 0.0% | -0.2% | -0.1% | |
| -3.6% | 5.7% | -6.5% | -15.1% | 71.1% | -6.5% | -21.2% | -10.6% | -8.8% | -10.2% | -5.3% | -13.0% | -9.4% | |
| 0.7% | 23.7% | -9.0% | -8.5% | 19.8% | -8.2% | -13.6% | 4.7% | 4.0% | -0.4% | -0.9% | -2.1% | 0.1% | |
| 4.4% | 19.9% | 2.1% | 11.2% | 10.0% | 13.0% | 7.4% | 15.8% | 14.9% | 10.9% | 5.7% | 10.8% | 10.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.